Rethinking Prenatal Migraine Management: The Clinical Case for Neuromodulation
October 8, 2026 |
Disclaimer: Management of migraine in pregnancy typically combines lifestyle strategies, nonpharmacologic approaches, selected pharmacologic options when benefits outweigh risks, and, increasingly, noninvasive neuromodulation technologies.
Listen to the full episode here.
In the high-stakes world of healthcare research and product development, success has long For decades, pregnant individuals suffering from severe migraines have faced an agonizing dilemma: endure debilitating pain or take prescription pharmaceuticals with uncertain fetal risk profiles. However, as three leading specialists argue in the latest Hear From Her podcast episode, suffering in silence is no longer an acceptable clinical protocol.
The Heavy Toll of Untreated Migraines
Migraine predominantly impacts women during their peak reproductive years. Far from a simple headache, it is a complex neurological disorder characterized by debilitating sensory sensitivities, nausea, and vomiting. When left unmanaged during pregnancy, the downstream physiological stress can be severe for both mother and fetus. Board-certified neurologist Dr. Deena Kuruvilla points out that uncontrolled migraines, particularly in the first trimester,have been associated in some observational studies with higher rates of adverse pregnancy
outcomes, though causality remains uncertain and confounding factors are common. As pregnancy progresses into the second and third trimesters, severe migraine attacks can cause blood pressure to climb, and may coexist with or signal higher‑risk pregnancies in which hypertensive disorders and preeclampsia are more common, which themselves are linked with low birth weight and abnormal placental function.
Listen to the full episode here.
Bridging the Awareness Gap with Neuromodulation
While traditional interventional strategies include lifestyle modifications, nutraceuticals (like magnesium), or procedural nerve blocks, a significant percentage of expecting mothers prefer a completely non-pharmacological route. This is where neuromodulation enters the conversation. Neuromodulation devices utilize localized electrical currents to safely disrupt and turn off the pain circuits traveling to the brain stem. Dr. Illa highlights two widely used, evidence-based options:
- Remote Electrical Neuromodulation (REN): A smartphone-controlled armband worn during acute attacks or every other day for prevention.
- External Trigeminal Nerve Stimulation (eTNS): An over-the-counter forehead adhesive device that gently stimulates the nerves directly involved in the migraine pathway.
From a perinatology perspective, Maternal-Fetal Medicine specialist Dr. Jolene Seibel-Seamon champions these devices for their favorable safety profile. Because the technology relies on localized nerve stimulation rather than chemical absorption, tthese devices deliver localized nerve stimulation without systemic drug exposure, so there is no concern for placental drug transfer, although pregnancy safety data remain limited and continue to be collected.
Despite robust clinical data, the primary barrier to widespread adoption remains a systemic lack of awareness. OB/GYN Dr. Michele Godorecci notes that many obstetricians and community neurologists remain unfamiliar with these technologies because they are not routinely emphasized in residency training. with these technologies because they are not actively taught in residency programs. To bridge this gap, the trio has co-authored advanced literature and initiated a comprehensive migraine pregnancy registry on ClinicalTrials.gov to continually build real-world evidence. Ultimately, modern prenatal care must expand to accommodate the patient’s autonomy, shifting away from a “one-size-fits-all” mentality and considering neuromodulation alongside established nonpharmacologic and pharmacologic options, and engaging patients in shared decision‑making tailored to their values and risk profiles.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Rethinking Prenatal Migraine Management: The Clinical Case for Neuromodulation
Disclaimer: Management of migraine in pregnancy typically combines lifestyle strategies, nonpharmacologic approaches, selected pharmacologic options when benefits outweigh risks, and, increasingly, noninvasive neuromodulation technologies.
Advancing the Frontier of Cancer Care: Medscape’s Mission at ESMO 2026
For more than 30 years, Medscape Education’s dedication has been centered on a single goal: building independent, accredited oncology education that improves patient outcomes. This year, at the European Society…
Using AI Responsibly in CME Outcomes Reporting
ICYMI at #AIS2026: using AI in outcomes reporting is a lot like onboarding a research assistant. There’s real efficiency in having the help, and a significant amount of background teaching,…
The Pulse of AI Innovation: From More Data to Better Care
At the European Society of Cardiology (ESC) Congress, two of cardiology’s most influential voices sat down to talk about artificial intelligence at Medscape’s ‘The Pulse of AI Innovation’ event: Professor…
Next-Level Clinical Practice, Real-World Impact: Evolving Patient Simulation with the Clinical Readiness Studio
Healthcare is changing rapidly, bringing unprecedented data and complex treatment pathways to the point of care. Clinical mastery requires active experience, the confidence to make decisions when real patient outcomes…
Medscape Sponsors The John Ritter Foundation’s “Evening From the Heart”
When independent, evidence-based education directly connects with clinicians at the point of care, clinical practice changes. Driven by this vital mission, Medscape Education was proud to sponsor The John Ritter…
From Booth to Bavaria: A Recap of Impact at ESC 2026
We have officially wrapped up another year at ESC. For Medscape Education, 4 days on the ground confirmed what 3 decades of cardiovascular education have already shown: when independent, evidence-based…
Why Modern Dermatology Demands Curiosity Over Precision
In the high-stakes world of healthcare research and product development, success has long been measured by rigid definitions of precision and predictable trajectories. However, as Dr. Hawa Dumbuya, Director of…
The Heart of the Matter: Medscape Education’s Cardiology Footprint at ESC 2026
For more than 30 years, Medscape Education has built independent, accredited cardiovascular education designed around one goal: improved patient outcomes. This year at the European Society of Cardiology Congress (ESC…
More Than Pink Walls: What Women-Centric Care Actually Requires
The phrase “patient-centered care” is tossed around freely in healthcare corporate boardrooms. Yet, for more than half the population, that promise routinely fractures. In the latest episode of the Hear…